Viewed: 1647
Emailed: 0
PDF Downloaded: 709
Full Text PDF Share on Facebook Share on Twitter
Original Article
Author Details :
Volume : 2, Issue : 2, Year : 2018
Article Page : 51-53
Abstract
Introduction: Type 2 Diabetes Mellitus (T2DM) is characterized by elevated glucose levels in circulating blood, caused by impairment in glucose tolerance development of insulin resistance & relative insulin deficiency.In the Indian population, insulin resistance is one of the strong reasons for altered glycemic control, even though exercise training is found to be useful in glycemic control along with the standard medical care.
Aim: To find out the effectiveness of structured exercise program on insulin resistance by using Fasting insulin level and Homa-IR in T2DM with peripheral neuropathy.
Material and Methods:In the study conducted, a total of 10 T2DM with peripheral neuropathy in the age group of 30 - 65 years were included. The criteria of exclusion for the participants were those with T1DM, respiratory disease, neurological disorders, and musculoskeletal problems.
Results: The average age of the participants was 58.80 ± 9.27. All the participants had a history of T2DM with a mean duration of 10.70 ± 6.29 years. All participants were screened clinically and biochemically and given a set of structured exercise program three times a week for 12 weeks along with standard medical care.
Conclusion: The 12 weeks of structured exercise program training was effective on insulin resistance and glycaemic control in T2DM with peripheral neuropathy.
Keywords:Insulin resistance, Aerobic exercise; Resistance training, Glycosylated HB, Homa-IR, Metabolic syndrome
How to cite : Kumar A S, Maiya G A, Shastry B A, Vaishali K, Effectiveness of structured exercise program on insulin resistance in type 2 diabetes mellitus with peripheral neuropathy – A preliminary report. J Soc Indian Physiother 2018;2(2):51-53
Copyright © 2018 by author(s) and J Soc Indian Physiother. This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License (creativecommons.org)